Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy — Stella

Home/Obsessive-Compulsive Disorder/CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy

View on ClinicalTrials.gov

Recruiting

Back to Obsessive-Compulsive Disorder trials

CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Boston University, Boston, Massachusetts

The University of Texas at Austin, Austin, Texas

Key details

Sponsor

University of Texas at Austin

Collaborators

Boston University, National Institute of Mental Health (NIMH)

Enrollment target

~600 participants

Started

November 2022

Primary completion

December 2026

Age range

18 Years – 70 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.